Filter
1334
Filtered Results: 1334
Text search:
clinical
manifestations
Featured
Recommendations
158
New Publications
277
Language
Document type
No document type
707
Guidelines
301
Studies & Reports
161
Manuals
65
Training Material
34
Fact sheets
28
Strategic & Response Plan
25
Situation Updates
6
Online Courses
3
Brochures
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
78
Global
52
Latin America and the Carribbean
37
South Africa
32
Colombia
25
Kenya
24
Ethiopia
23
Brazil
21
Western and Central Europe
20
Argentina
19
Sierra Leone
18
Nigeria
18
Africa
18
Uganda
18
Germany
16
Tanzania
14
Paraguay
14
Ghana
12
Liberia
12
Rwanda
11
Philippines
11
Russia
11
Nepal
10
Ukraine
9
Venezuela
9
Bangladesh
9
Ecuador
9
Senegal
8
Mozambique
8
Congo, Democratic Republic of
7
West and Central Africa
7
Eastern Europe
7
Namibia
7
Zambia
7
Guinea
6
Spain
6
Chile
5
Burkina Faso
5
Peru
5
USA
5
East and Southern Africa
5
Bolivia
5
Botswana
5
Benin
4
Syria
4
Zimbabwe
4
Cambodia
4
Asia
4
South–East Asia Region
4
Côte d’Ivoire / Ivory Coast
4
Mali
4
Indonesia
4
Eswatini/ Swaziland
4
El Salvador
3
Haiti
3
Middle East and North Africa
3
France
3
Angola
3
Cameroon
2
Iran
2
Albania
2
Canada
2
Malawi
2
Morocco
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Sudan
2
South Sudan
2
Iraq
2
Myanmar / Burma
2
Madagascar
2
North Macedonia
1
Tajikistan
1
Switzerland
1
Lesotho
1
Togo
1
China
1
Fiji
1
Laos
1
Estonia
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Burundi
1
Dominican Republic
1
Jordan
1
Ireland
1
Saudi Arabia
1
Luxembourg
1
North America
1
Uruguay
1
Belgium
1
Tunisia
1
Portugal
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Egypt
1
Greece
1
Georgia
1
Central African Republic
1
Honduras
1
Chad
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
448
Clinical Guidelines
228
Public Health
67
Women & Child Health
38
Capacity Building
22
Key Resources
15
Pharmacy & Technologies
11
Toolboxes
COVID-19
170
Mental Health
168
NTDs
94
TB
93
HIV
83
Rapid Response
76
Ebola
40
NCDs
38
Zika
30
Caregiver
22
Pharmacy
22
Refugee
21
Disability
16
AMR
15
Global Health Education
14
Planetary Health
12
Specific Hazards
9
Polio
9
Social Ethics
8
Conflict
8
Cholera
5
Natural Hazards
4
Development of cardiovascular disease (CVD) is influenced by risk factors such as:
tobacco use, an unhealthy diet, physical inactivity, obesity (which can result from
a combination of unhealthy diet, physical inactivity, and other factors), elevated
blood pressure (hypertension), abnormal blood l...
Two decades of epidemiological research shows that silent cerebrovascular disease is common and is associated with future risk for stroke and dementia. It is the most common incidental finding on brain scans. To summarize evidence on the diagnosis and management of silent cerebrovascular disease to ...
El 31 de diciembrede 2019 las Autoridades de la República Popular China, comunicaron a la OMS varios casos de neumonía de etiología desconocida en Wuhan, una ciudad situada en la provincia china de Hubei. Una semana más tarde confirmaron que se trataba de un nuevo co...
El presente protocolo es una actualización del emitido el 24 de abril 2020 y contiene las
siguientes modificaciones:
• Definición de caso: Las definiciones de caso sospechoso y confirmado son dinámicas y secundarias a la situación epidemiológica vigente. En este contexto el Ministerio de
...
Leptospirosis is a perplexing conundrum for many. In the existing literature, the pathophysiological mechanisms pertaining to leptospirosis is still not understood in full. Considered as a neglected tropical zoonotic disease, leptospirosis is culminating as a serious problem worldwide, seemingly exi...
Ce document d'orientation est destiné aux cliniciens qui s'occupent de patients atteints de COVID-19 à toutes les phases de leur maladie (c'est-à-dire du dépistage à la sortie de l'hôpital). Cette mise à jour a été étendue pour répondre aux besoins des cliniciens de première ligne et fa...
Evidencias COVID-19 es un recurso que ofrece información relevante relacionada con la pandemia del coronavirus SARS-CoV-2 y la COVID-19.
Este recurso recoge una serie de documentos que sintetizan la información más relevante para dar respuesta a preguntas clínicas y temas prioritarios sobre l...
Over 2 million children worldwide are living with HIV infection and 95% reside in sub-Saharan Africa with the majority infected through mother-to-child transmission. Infected children have a high mortality with 50% dying by 2 years of age. Their clinical presentation includes common childhood infect...
Handbook For Clinical Management Of Dengue
recommended
Clinical management handbook
Journal of the ASEAN Federation of Endocrine Societies ; Vol.27 No.1 May 2012 ; Page 34-39
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
